In vivo antithrombotic potential of protease from Bacillus thuringiensis HSFI-12

In vivo antithrombotic potential of protease from Bacillus thuringiensis HSFI-12

Background/Aim: Cardiovascular diseases (CVDs) are the primary noncommunicable disease at the global level due to abnormal platelet aggregation by fibrin forming clots in blood vessels called thrombus. The search for thrombolytic drugs is largely carried out to treat thrombosis. Crude extract and di...

Full description

Bibliographic Details
Main Authors: Dewi Okta Yosiana, Zilda Dewi Seswita, Rakhmawatie Maya Dian, Samiasih Amin, Ethica Stalis Norma
Format: Article
Language:English
Published: Medical Society of the Republic of Srpska, Banja Luka, University of Banja Luka. Faculty of Medicine 2023-01-01
Series:Scripta Medica
Subjects:
bacillus thuringiensis hsfi-12
cardiovascular diseases
carrageenan induction
in vivo thrombolytic test
thrombolytic agent
Online Access:https://scindeks-clanci.ceon.rs/data/pdf/2490-3329/2023/2490-33292303229D.pdf

Internet

https://scindeks-clanci.ceon.rs/data/pdf/2490-3329/2023/2490-33292303229D.pdf

Similar Items